Skip to main content
[Preprint]. 2023 Aug 31:2023.08.28.23294700. [Version 1] doi: 10.1101/2023.08.28.23294700

Figure 2.

Figure 2.

Frequency of pharmacological treatment: Dopaminergic agonists (DA) and levodopa and other as a function of age group (A) and HY stage (B). There was no difference of treatment as a function of age (A) or stage (B; p>0.05). Percentage of patients by the location of the initial symptoms (C). Years of delay in the diagnosis (D).